AEON Biopharma Inc (AMEX:AEON) has a beta value of -0.05 and has seen 15.98 million shares traded in the last trading session. The company, currently valued at $11.06M, closed the last trade at $0.14 per share which meant it gained $0.01 on the day or 8.05% during that session. The AEON stock price is -12164.29% off its 52-week high price of $17.17 and 28.57% above the 52-week low of $0.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 79.3 million shares traded. The 3-month trading volume is 15.65 million shares.
The consensus among analysts is that AEON Biopharma Inc (AEON) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.18.
AEON Biopharma Inc (AMEX:AEON) trade information
Sporting 8.05% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the AEON stock price touched $0.14 or saw a rise of 13.9%. Year-to-date, AEON Biopharma Inc shares have moved -74.39%, while the 5-day performance has seen it change -19.08%. Over the past 30 days, the shares of AEON Biopharma Inc (AMEX:AEON) have changed -78.72%. Short interest in the company has seen 0.16 million shares shorted with days to cover at 1.6.
AEON Biopharma Inc (AEON) estimates and forecasts
The company’s shares have lost -94.76% over the past 6 months, compared to 16.40% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
AEON Dividends
AEON Biopharma Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
Insiders own 36.23% of the company shares, while shares held by institutions stand at 33.14% with a share float percentage of 51.98%. Investors are also buoyed by the number of investors in a company, with AEON Biopharma Inc having a total of 34.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 1.04% shares in the company for having 414.9 shares of worth $57380.0 while later fund manager owns 320.9 shares of worth $44380.0 as of Sep 30, 2024 , which makes it owner of about 0.80% of company’s outstanding stock.
